Gland Pharma intimated exchanges about an upcoming ESOP Compensation Committee meeting.
The meeting on May 15, 2026 will consider granting stock options under ESOP 2025 scheme.
The disclosure was signed by Company Secretary Sampath Kumar Pallerlamudi on May 12, 2026.